QA Dry External Manufacturing (Drug product & Packaging) Associate at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • BS in a science-related field such as Pharmacy, Chemistry, Biological Sciences or related Life Sciences
  • 3+ years previous GMP manufacturing knowledge and/or experience in API/intermediates or finished product manufacturing, QC, QA or Engineering
  • Must complete required training for Dry-EM Quality Assurance

Responsibilities

  • Serve as a liaison between CMs and Lilly
  • Provide quality oversight of CMs including being the initial point of contact for all quality-related issues
  • Escalate quality issues at CMs to Lilly QA management
  • Assist in the establishment and revisions of Quality Agreements with affiliates and customers
  • Ensure compliance to Quality Agreements and Manufacturing Responsibilities Documents (MRDs)
  • Provide quality oversight of Lilly/Dry-EM Quality Plans
  • Coordinate and perform QA responsibilities of Bulk/finished product shipments
  • Participate in regulatory inspection preparations with CMs and provide on-site support during inspections
  • Participate on the Technical Review Board
  • Evaluate and disposition batches of bulk and finished product, if required
  • Ensure that documented checks have been completed for the Certificates of Testing and Certificates of Environmental Monitoring (where applicable), and deviations, changes and batch documentation that demonstrates requirements have been met prior to batch release
  • Provide quality support of the manufacturing process for bulk (capsules and tablets) and packaged products with the focus on holistic review of key activities associated with or impacting the manufacturing processes including deviations, change controls and countermeasures
  • Assess the impact of deviation investigations and changes and ensure that all appropriate records are documented and retrievable
  • Ensure all processes are in an appropriate state of control
  • Maintain awareness of external regulatory agency findings which individually or collectively reference the quality of the product
  • Review and approve documents including, but not limited to, procedures, master production records, change control proposals, deviations, equipment qualifications, analytical methods and computerized system validations
  • Participate in APR activities
  • Participate in projects to improve productivity
  • Participate in Joint Process (JPT) and Post Launch Optimization (PLOT) Teams

Skills

cGMP
Quality Assurance
Regulatory Compliance
Batch Disposition
Quality Agreements
Deviation Management
Change Control
Environmental Monitoring
Inspection Preparation
Technical Review

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI